|
|
|
Research Papers
Program in Molecular Medicine, University of Massachusetts Medical Center, Worcester 01605.
Abstract
The Tat protein of human immunodeficiency virus type 1 (HIV-1) activates transcription following binding to nascent trans-activation response (TAR) RNA downstream of the transcription start site. Because Tat functions when bound to RNA, and in a position-dependent manner, it has been proposed that Tat works by a novel mechanism. Here, we perform a series of protein fusion experiments that reveal striking similarities between Tat and conventional cellular activators. Most significantly, we demonstrate that Tat can function when bound to upstream promoter DNA. This activity depends on a region within Tat that is also required for Tat to function when bound to TAR RNA. In contrast, the arginine-rich region of Tat, which is required for binding to TAR RNA, is dispensable for the function of DNA-bound Tat. When bound either to RNA or DNA Tat activity requires cooperation with promoter-bound cellular transcription factors. Finally, we show that Tat and a strong acidic activator stimulate transcription to comparable levels. On the basis of these and other results we suggest that Tat and acidic activators act on a similar step in the transcription process.
This article has been cited by other articles:
![]() |
I. Oven, N. Brdickova, J. Kohoutek, T. Vaupotic, M. Narat, and B. M. Peterlin AIRE Recruits P-TEFb for Transcriptional Elongation of Target Genes in Medullary Thymic Epithelial Cells Mol. Cell. Biol., December 15, 2007; 27(24): 8815 - 8823. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. H. Dandekar, K. N. Ganesh, and D. Mitra HIV-1 Tat directly binds to NF{kappa}B enhancer sequence: role in viral and cellular gene expression Nucleic Acids Res., February 23, 2004; 32(4): 1270 - 1278. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. S. R. K. Yedavalli, M. Benkirane, and K.-T. Jeang Tat and Trans-activation-responsive (TAR) RNA-independent Induction of HIV-1 Long Terminal Repeat by Human and Murine Cyclin T1 Requires Sp1 J. Biol. Chem., February 14, 2003; 278(8): 6404 - 6410. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Ambrosino, C. Palmieri, A. Puca, F. Trimboli, M. Schiavone, F. Olimpico, M. R. Ruocco, F. di Leva, M. Toriello, I. Quinto, et al. Physical and Functional Interaction of HIV-1 Tat with E2F-4, a Transcriptional Regulator of Mammalian Cell Cycle J. Biol. Chem., August 23, 2002; 277(35): 31448 - 31458. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. L. Wiegand, G. A. Coburn, Y. Zeng, Y. Kang, H. P. Bogerd, and B. R. Cullen Formation of Tap/NXT1 Heterodimers Activates Tap-Dependent Nuclear mRNA Export by Enhancing Recruitment to Nuclear Pore Complexes Mol. Cell. Biol., January 1, 2002; 22(1): 245 - 256. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Taube, X. Lin, D. Irwin, K. Fujinaga, and B. M. Peterlin Interaction between P-TEFb and the C-Terminal Domain of RNA Polymerase II Activates Transcriptional Elongation from Sites Upstream or Downstream of Target Genes Mol. Cell. Biol., January 1, 2002; 22(1): 321 - 331. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Browning, M. J. Smith, N. M. Clark, B. R. Lane, C. Parada, M. Montano, V. N. KewalRamani, D. R. Littman, M. Essex, R. G. Roeder, et al. Human GLI-2 Is a Tat Activation Response Element-Independent Tat Cofactor J. Virol., March 1, 2001; 75(5): 2314 - 2323. [Abstract] [Full Text] |
||||
![]() |
H. P. Bogerd, H. L. Wiegand, J. Yang, and B. R. Cullen Mutational Definition of Functional Domains within the Rev Homolog Encoded by Human Endogenous Retrovirus K J. Virol., October 15, 2000; 74(20): 9353 - 9361. [Abstract] [Full Text] |
||||
![]() |
F. Kashanchi, E. T. Agbottah, C. A. Pise-Masison, R. Mahieux, J. Duvall, A. Kumar, and J. N. Brady Cell Cycle-Regulated Transcription by the Human Immunodeficiency Virus Type 1 Tat Transactivator J. Virol., January 1, 2000; 74(2): 652 - 660. [Abstract] [Full Text] |
||||
![]() |
J. Yang, H. P. Bogerd, S. Peng, H. Wiegand, R. Truant, and B. R. Cullen An ancient family of human endogenous retroviruses encodes a functional homolog of the HIV-1 Rev protein PNAS, November 9, 1999; 96(23): 13404 - 13408. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. F. Marshall, G. K. Dahmus, and M. E. Dahmus Regulation of Carboxyl-terminal Domain Phosphatase by HIV-1 Tat Protein J. Biol. Chem., November 27, 1998; 273(48): 31726 - 31730. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. P. Bogerd, A. Echarri, T. M. Ross, and B. R. Cullen Inhibition of Human Immunodeficiency Virus Rev and Human T-Cell Leukemia Virus Rex Function, but Not Mason-Pfizer Monkey Virus Constitutive Transport Element Activity, by a Mutant Human Nucleoporin Targeted to Crm1 J. Virol., November 1, 1998; 72(11): 8627 - 8635. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Daviet, F. Bois, P.-L. Battisti, and A. Gatignol Identification of Limiting Steps for Efficient Trans-activation of HIV-1 Promoter by Tat in Saccharomyces cerevisiae J. Biol. Chem., October 23, 1998; 273(43): 28219 - 28228. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Herold, R. Truant, H. Wiegand, and B. R. Cullen Determination of the Functional Domain Organization of the Importin alpha Nuclear Import Factor J. Cell Biol., October 19, 1998; 143(2): 309 - 318. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-Y. Li and M. R Green The HIV-1 Tat cellular coactivator Tat-SF1 is a general transcription elongation factor Genes & Dev., October 1, 1998; 12(19): 2992 - 2996. [Abstract] [Full Text] |
||||
![]() |
J. W. Maciaszek, S. J. Coniglio, D. A. Talmage, and G. A. Viglianti Retinoid-Induced Repression of Human Immunodeficiency Virus Type 1 Core Promoter Activity Inhibits Virus Replication J. Virol., July 1, 1998; 72(7): 5862 - 5869. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Lodie, M. Reiner, S. Coniglio, G. Viglianti, and M. J. Fenton Both PU.1 and Nuclear Factor-{kappa}B Mediate Lipopolysaccharide-Induced HIV-1 Long Terminal Repeat Transcription in Macrophages J. Immunol., July 1, 1998; 161(1): 268 - 276. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. O. Gold, X. Yang, C. H. Herrmann, and A. P. Rice PITALRE, the Catalytic Subunit of TAK, Is Required for Human Immunodeficiency Virus Tat Transactivation In Vivo J. Virol., May 1, 1998; 72(5): 4448 - 4453. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Dyer, P. J. Hayes, and M. H. Baron The HMG Domain Protein SSRP1/PREIIBF Is Involved in Activation of the Human Embryonic beta -Like Globin Gene Mol. Cell. Biol., May 1, 1998; 18(5): 2617 - 2628. [Abstract] [Full Text] |
||||
![]() |
R. Tan and A. D. Frankel A novel glutamine-RNA interaction identified by screening libraries in mammalian cells PNAS, April 14, 1998; 95(8): 4247 - 4252. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. F. Chun, O. J. Semmes, C. Neuveut, and K.-T. Jeang Modulation of Sp1 Phosphorylation by Human Immunodeficiency Virus Type 1 Tat J. Virol., April 1, 1998; 72(4): 2615 - 2629. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Xiao, Y. Tao, J. Greenblatt, and R. G. Roeder A cofactor, TIP30, specifically enhances HIV-1 Tatactivated transcription PNAS, March 3, 1998; 95(5): 2146 - 2151. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. McDonough, D. S. Hanford, A. B. Sprenkle, N. R. Mellon, and C. C. Glembotski Collaborative Roles for c-Jun N-terminal Kinase, c-Jun, Serum Response Factor, and Sp1 in Calcium-regulated Myocardial Gene Expression J. Biol. Chem., September 19, 1997; 272(38): 24046 - 24053. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. F. Garcia-Martinez, D. Ivanov, and R. B. Gaynor Association of Tat with Purified HIV-1 and HIV-2 Transcription Preinitiation Complexes J. Biol. Chem., March 14, 1997; 272(11): 6951 - 6958. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. F. Chun and K.-T. Jeang Requirements for RNA Polymerase II Carboxyl-terminal Domain for Activated Transcription of Human Retroviruses Human T-Cell Lymphotropic Virus I and HIV-1 J. Biol. Chem., November 1, 1996; 271(44): 27888 - 27894. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Krumm, L B Hickey, and M Groudine Promoter-proximal pausing of RNA polymerase II defines a general rate-limiting step after transcription initiation. Genes & Dev., March 1, 1995; 9(5): 559 - 572. [Abstract] [PDF] |
||||
![]() |
P Carlsson, M L Waterman, and K A Jones The hLEF/TCF-1 alpha HMG protein contains a context-dependent transcriptional activation domain that induces the TCR alpha enhancer in T cells. Genes & Dev., December 1, 1993; 7(12a): 2418 - 2430. [Abstract] [PDF] |
||||
![]() |
L S Tiley, S J Madore, M H Malim, and B R Cullen The VP16 transcription activation domain is functional when targeted to a promoter-proximal RNA sequence. Genes & Dev., November 1, 1992; 6(11): 2077 - 2087. [Abstract] [PDF] |
||||
![]() |
H Kato, H Sumimoto, P Pognonec, C H Chen, C A Rosen, and R G Roeder HIV-1 Tat acts as a processivity factor in vitro in conjunction with cellular elongation factors. Genes & Dev., April 1, 1992; 6(4): 655 - 666. [Abstract] [PDF] |
||||
![]() |
K. K. C. Li and K. A. W. Lee Transcriptional Activation by the Ewing's Sarcoma (EWS) Oncogene Can Be Cis-repressed by the EWS RNA-binding Domain J. Biol. Chem., July 21, 2000; 275(30): 23053 - 23058. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. Neufeld, D. A. Nix, H. Bogerd, Y. Kang, M. C. Beckerle, B. R. Cullen, and R. L. White Adenomatous polyposis coli protein contains two nuclear export signals and shuttles between the nucleus and cytoplasm PNAS, October 24, 2000; 97(22): 12085 - 12090. [Abstract] [Full Text] [PDF] |
||||